J Pediatr Intensive Care 2014; 03(04): 255-267
DOI: 10.3233/PIC-14112
Review Article
Georg Thieme Verlag KG Stuttgart – New York

Adjunctive and novel therapies for sepsis

Jennifer A. Muszynski
a   Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA
b   The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA
,
W. Joshua Frazier
a   Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA
,
Mark W. Hall
a   Division of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA
b   The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA
› Institutsangaben

Verantwortlicher Herausgeber dieser Rubrik:
Weitere Informationen

Publikationsverlauf

09. Oktober 2014

29. Oktober 2014

Publikationsdatum:
28. Juli 2015 (online)

Zoom Image

Abstract

Primary goals of sepsis therapy include early, appropriate antimicrobial therapy and prompt recognition and reversal of shock. Despite these measures, however, sepsis remains an important source of pediatric morbidity and mortality. Here we review rationale and existing evidence in support of adjunctive sepsis therapies including extracorporeal support, immunomodulation, and mitochondria-targeted therapies. While each of these therapeutic modalities shows promise, additional studies are urgently needed to identify the right patients, the right timing, and the right context for these interventions.